AVMA news
Drugs treating epilepsy, feline diabetes receive FDA approval
The Food and Drug Administration (FDA) has recently approved a number of animal drugs, including those that treat idiopathic epilepsy in dogs and…
JAVMA news
Board takes on topics across breadth of profession
The AVMA Board of Directors, while meeting June 20-21 in Washington, D.C., took on topics across the breadth of the profession, including improvement…
JAVMA news
FDA finalizes guidance on therapeutic pet food
The Food and Drug Administration has finalized guidance that the agency drafted in response to the increasing number of therapeutic pet diets and…
JAVMA news
APHIS may change swine disease programs
A proposal from federal animal health officials would have states develop swine health plans as part of a national program to
JAVMA news
USDA exempts more exhibitors, owners from licensing
People who breed and sell only a few, nondangerous animals or who seldom exhibit such animals are exempt from federal licensing requirements.
JAVMA news
More large-volume fluids become available
More large-volume polyionic fluids for parenteral administration in large animals have become available during an ongoing shortage.
AVMA news
FDA to resume enforcement of all federal VCPR requirements for veterinary telemedicine
Starting Feb. 21, the Food and Drug Administration will again hold veterinarians to the federal requirements for the veterinarian-client-patient…
AVMA news
In Memory – January 4, 2024
Veterinarian obituaries in the “In Memory” section of the Journal of the AVMA, January 4, 2024
AVMA news
FDA approves first animal drug for Giardia duodenalis, additional drugs for cows, swine
The Food and Drug Administration (FDA) has recently approved a number of animal drugs, including those that treat Giardia duodenalis in dogs.
blog
AVMA prepares response to FDA draft compounding guidance
Based on feedback from member veterinarians and other stakeholders, the AVMA has compiled a list of key points to share with the FDA in our formal…
JAVMA news
Recalled mirtazapine may have double the labeled strength
Mislabeled mirtazapine bottles could contain tablets with double the expected strength, according to a warning from the Food and Drug Administration.
AVMA news
In Memory – June 9, 2022
Veterinarian obituaries in the “In Memory” section of the Journal of the AVMA, June 9, 2022
blog
FDA grants AVMA request to extend comments on compounding from bulk drugs
The extension means AVMA members have until April 20 to provide feedback to inform the AVMA's formal comments on the proposal.
AVMA news
In Memory: Childers, dedicated volunteer and practitioner, dies at 93
Dr. Henry E. Childers, a Rhode Island practitioner and former president of the AVMA and the American Hospital Association, died April 15, 2024. He was…
JAVMA news
Though COVID-19 cases rare in pets, testing is available
Veterinarians can test for the COVID-19 virus in animals, but whether and when they should still remain issues. At press time in late April, only a…